210 related articles for article (PubMed ID: 34232734)
1. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
[TBL] [Abstract][Full Text] [Related]
2. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
Peng C; Moss B
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
[TBL] [Abstract][Full Text] [Related]
3. SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.
Liu R; Mendez-Rios JD; Peng C; Xiao W; Weisberg AS; Wyatt LS; Moss B
PLoS Pathog; 2019 May; 15(5):e1007710. PubMed ID: 31145755
[TBL] [Abstract][Full Text] [Related]
4. The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in mice.
Liu SW; Wyatt LS; Orandle MS; Minai M; Moss B
J Virol; 2014 Jan; 88(1):202-11. PubMed ID: 24155373
[TBL] [Abstract][Full Text] [Related]
5. Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells.
Peng C; Wyatt LS; Glushakow-Smith SG; Lal-Nag M; Weisberg AS; Moss B
PLoS Pathog; 2020 Aug; 16(8):e1008845. PubMed ID: 32866210
[TBL] [Abstract][Full Text] [Related]
6. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
[TBL] [Abstract][Full Text] [Related]
7. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
[TBL] [Abstract][Full Text] [Related]
8. Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.
Melamed S; Wyatt LS; Kastenmayer RJ; Moss B
Vaccine; 2013 Sep; 31(41):4569-77. PubMed ID: 23928462
[TBL] [Abstract][Full Text] [Related]
9. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
10. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
Meisinger-Henschel C; Schmidt M; Lukassen S; Linke B; Krause L; Konietzny S; Goesmann A; Howley P; Chaplin P; Suter M; Hausmann J
J Gen Virol; 2007 Dec; 88(Pt 12):3249-3259. PubMed ID: 18024893
[TBL] [Abstract][Full Text] [Related]
11. Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.
Alharbi NK; Chinnakannan SK; Gilbert SC; Draper SJ
PLoS One; 2015; 10(5):e0127978. PubMed ID: 26011541
[TBL] [Abstract][Full Text] [Related]
12. A Poxvirus Decapping Enzyme Colocalizes with Mitochondria To Regulate RNA Metabolism and Translation and Promote Viral Replication.
Cao S; Molina JA; Cantu F; Hernandez C; Yang Z
mBio; 2022 Jun; 13(3):e0030022. PubMed ID: 35435699
[TBL] [Abstract][Full Text] [Related]
13. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
14. Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme.
Soulière MF; Perreault JP; Bisaillon M
Nucleic Acids Res; 2010 Nov; 38(21):7599-610. PubMed ID: 20639534
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.
Senkevich TG; Zhivkoplias EK; Weisberg AS; Moss B
J Virol; 2020 Aug; 94(18):. PubMed ID: 32669330
[TBL] [Abstract][Full Text] [Related]
16. The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
Sperling KM; Schwantes A; Staib C; Schnierle BS; Sutter G
J Virol; 2009 Jun; 83(12):6029-38. PubMed ID: 19357172
[TBL] [Abstract][Full Text] [Related]
17. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
18. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
[TBL] [Abstract][Full Text] [Related]
19. Truncation of gene F5L partially masks rescue of vaccinia virus strain MVA growth on mammalian cells by restricting plaque size.
Dobson BM; Tscharke DC
J Gen Virol; 2014 Feb; 95(Pt 2):466-471. PubMed ID: 24145605
[TBL] [Abstract][Full Text] [Related]
20. A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).
Jordan I; Horn D; Thiele K; Haag L; Fiddeke K; Sandig V
Virol Sin; 2020 Apr; 35(2):212-226. PubMed ID: 31833037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
